Navigation Links
Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
Date:9/28/2010

BONITA SPRINGS, Fla. and NEW YORK, Sept. 28 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held drug development company, announced today that it has completed a private placement of Series C Convertible Preferred Stock resulting in gross proceeds of approximately $6.5 million.  The financing, which was led by Mr. Neil Flanzraich, also included current investors Wexford Spectrum Investors, LLC, and Sonostar Capital Partners, LLC and other institutional and individual investors.  Riverbank Capital Securities, Inc. acted as placement agent in connection with the financing.  

Tigris intends to use the proceeds from the financing primarily to advance the development of its clinical product pipeline, including its lead compound, Aminoflavone pro-drug (AFP-464), a novel anticancer agent.  A multi-center, Phase I, ascending dose clinical study of AFP-464 has been completed in Europe at Institut Gustave-Roussy, Villejuif, France and Jules Bordet Institute, Brussels, Belgium.  The company expects to initiate a multi-site phase II breast cancer study in 2010.  AFP-464's mechanism of action has shown that AFP-464 is converted to metabolites which bind covalently to DNA, resulting in p53 activation and apoptosis.  AFP-464 has shown a unique pattern of growth inhibitory activity in the tumor cell line screening, with breast, ovarian, lung and renal tumor cell lines exhibiting particular sensitivity to the compound.  In vivo antitumor activity of AFP-464 has been demonstrated in several Xenograft models in mice bearing breast and renal cancer.

Additionally, Tigris is currently conducting a multi-center Phase I dose escalation trial for GGTI-2418, another first-in-class agent, at Abramson Cancer Center at the University of Pennsylvania and Indiana University Melvin and Bren Simon Cancer Center.  GGTI-2418 is a synthetic peptidomimetic inhibitor of geranylgeranyltransferase I (GGTase I) that appears to
'/>"/>

SOURCE Tigris Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
2. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
3. Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
8. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... Award for Vision, Innovation, and Leadership has been awarded to ... award recognizes an individual who has had a significant impact ... for several decades. "I am honored to ... Peltz , Ph.D., CEO of PTC Therapeutics, Inc. "When I ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
(Date:11/21/2014)... 2014  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, announced today that it will ... a strong launch of Edwards Lifesciences Foundation,s new charitable ... the global communities where its employees live and work. ... will exceed $8 million, including more than $7 million ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2
(Date:11/23/2014)... More than two dozen new claims were ... involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), as well as ... , A Case List updated on November 17th ... 2 diabetes medications referred to as incretin mimetics have ... District of California, where a federal proceeding continues to ...
(Date:11/23/2014)... 2014 The FDA is Watching: , ... On-Demand Webinar**, Dec. 11, 2014 ? Any Time at ... focus on promotional activities is no longer limited to ... looking at websites, Twitter, journal articles, TV appearances, Facebook ... Dec. 11, for On-Demand access to Timothy Ayers and ...
(Date:11/23/2014)... 23, 2014 Today Zane Benefits, ... small businesses, announced their new on demand webinar ... Employer-Provided Health Insurance. , According to ... financial risk facing most American families. It is ... and large, when it comes to recruiting and ...
(Date:11/22/2014)... PrettyTailor , an outstanding dress company, ... promotion. Customers can buy new dresses at its online ... its website. , As a matter of fact, PrettyTailor ... mainly provides four types of wedding outfits, including bridesmaid ... dresses. It also provides a variety of occasion dresses, ...
(Date:11/22/2014)... BambooFlooringChina.com is a famous brand in ... its new collection of bamboo mats ; the new ... off. , According to the sales manager of ... it a highly renewable resource. Their bamboo mats are 100% ... which comes from natural bamboo with caramel bamboo strips. ...
Breaking Medicine News(10 mins):Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2
... EBITDA Quarter in Q3 2009PURCHASE, N.Y., May 12 ... developer and marketer of nutritional supplements under the Iceland ... manage blood sugar levels, improve cardiovascular health, enhance memory ... for the third quarter and the first nine months ...
... in email and file archiving solutions for ... management, today announces the release of the ... the award-winning MessageSolution Enterprise Email Archive at ... MessageSolution,s SaaS email archiving solution supports ...
... CCHIT recognizes its functionality; CureMD EHR v10 CCHIT 08 Certified ... ... May 12, 2009 -- The Certification Commission for Healthcare Information ... updated interoperability requirements, is a conditionally CCHIT Certified® 08 Ambulatory ...
... beneficiaries are more satisfied with their health care, and ... Americans with employer-sponsored insurance (ESI), according to a study ... Health Affairs Web site. , The study ... Biennial Health Insurance Survey, a nationally representative survey of ...
... Chemical Entity for Topical Acne Treatment in a DecadeCARLSBAD, Calif., ... has entered into a co-promotion agreement with Allergan for ... vulgaris. Representing the first new molecule in a decade approved ... patients 12 years of age and older, ACZONE(R) Gel 5% ...
... 11 Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) ... of shares of common stock at $1.25 per share and ... offering to a single institutional investor. The Company currently expects ... hand and/or cash received in connection with this offering to ...
Cached Medicine News:Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 2Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 3Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 4Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 5Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 6Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 7Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 2Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 3Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 4Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 5Health News:Doctors Love its Usability & CCHIT Recognizes its Functionality; CureMD EHR v10 CCHIT 08 Certified 2Health News:Doctors Love its Usability & CCHIT Recognizes its Functionality; CureMD EHR v10 CCHIT 08 Certified 3Health News:Elderly Medicare beneficiaries give their coverage higher ratings than do those with ESI 2Health News:Elderly Medicare beneficiaries give their coverage higher ratings than do those with ESI 3Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 2Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 3Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 4Health News:Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $20 Million of Common Stock and Warrants 2
This fume hood features a one-piece shell molded of polyethylene with a clear acrylic panel that slides on inside tracks. It can be set in an open, closed or intermediate position....
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
... Microtome is ideal for sectioning of specimens in ... Specimen rise is automatic and accurate with section ... increments of 2 microns. Will accommodate MNL ... Vibratomes Freezing Stages , ...
... Gold Package is the ultimate ... package includes the Vibratome 3000 ... starter package accessory kit, additional ... mounts 1/2" head, rotating stage, ...
Medicine Products: